These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 26264761)

  • 1. The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
    Duncan HF; Smith AJ; Fleming GJ; Partridge NC; Shimizu E; Moran GP; Cooper PR
    J Cell Physiol; 2016 Apr; 231(4):798-816. PubMed ID: 26264761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells.
    Duncan HF; Smith AJ; Fleming GJ; Cooper PR
    Exp Cell Res; 2013 Jun; 319(10):1534-43. PubMed ID: 23562654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
    Duncan HF; Smith AJ; Fleming GJ; Cooper PR
    J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
    Qiu X; Rong X; Yang J; Lu Y
    BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
    Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D
    Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
    Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC
    PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells.
    Beliakova-Bethell N; Zhang JX; Singhania A; Lee V; Terry VH; Richman DD; Spina CA; Woelk CH
    AIDS; 2013 Jan; 27(1):29-37. PubMed ID: 23221426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid (vorinostat): its role on equine corneal fibrosis and matrix metalloproteinase activity.
    Donnelly KS; Giuliano EA; Sharm A; Mohan RR
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():61-8. PubMed ID: 25126665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity.
    Tan J; Zhuang L; Jiang X; Yang KK; Karuturi KM; Yu Q
    J Biol Chem; 2006 Apr; 281(15):10508-15. PubMed ID: 16476732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Deacetylase Inhibitors Enhance Cytotoxicity Towards Breast Tumors While Preserving the Wound-Healing Function of Adipose-Derived Stem Cells.
    Koko KR; Chang S; Hagaman AL; Fromer MW; Nolan RS; Gaughan JP; Zhang P; Carpenter JP; Brown SA; Matthews M; Bird D
    Ann Plast Surg; 2017 Jun; 78(6):728-735. PubMed ID: 28489652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
    Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo.
    Dincman TA; Beare JE; Ohri SS; Gallo V; Hetman M; Whittemore SR
    Int J Dev Neurosci; 2016 Nov; 54():53-61. PubMed ID: 27587342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Deacetylase Inhibitor Vorinostat (SAHA) Suppresses IL-1β-Induced Matrix Metallopeptidase-13 Expression by Inhibiting IL-6 in Osteoarthritis Chondrocyte.
    Makki MS; Haqqi TM
    Am J Pathol; 2016 Oct; 186(10):2701-8. PubMed ID: 27555113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of miRNA Expression in Dental Pulp Cells during Epigenetically-Driven Reparative Processes.
    Kearney M; Cooper PR; Smith AJ; Duncan HF
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of suberoylanilide hydroxamic acid (SAHA) regulated genes in mineralizing dental pulp cells at early and late time points.
    Duncan HF; Smith AJ; Fleming GJ; Moran GP; Cooper PR
    Genom Data; 2015 Sep; 5():391-3. PubMed ID: 26484294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.